
    
      A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled,
      Study To Evaluate Efficacy, Safety And Tolerability Of Oral GW677954 Capsules (2.5, 5, 10, 15
      And 20 Mg Once A Day) As A Monotherapy (Diet and/or exercise treated) Or As An Add-On To
      Metformin For 16 Weeks Duration In Subjects With Type 2 Diabetes Mellitus
    
  